[DFAN14A] Core Scientific, Inc./tx SEC Filing
Two Seas Capital, a major Core Scientific (NASDAQ: CORZ) shareholder, filed definitive additional proxy materials urging a vote AGAINST the proposed sale to CoreWeave (announced July 7, 2025). In a letter to shareholders, Two Seas argues the deal substantially undervalues Core Scientific.
The firm cites an implied value of about $17.50 per share based on the 0.1235 exchange ratio and CoreWeave’s October 16, 2025 stock price, noting CORZ has traded above the daily implied deal value for 44 straight trading days, by an average of 13%. Two Seas highlights sector transactions and peer stock performance to suggest greater standalone upside and asks holders to use the GOLD proxy card to vote against the transaction.
Two Seas Capital, un importante socio di Core Scientific (NASDAQ: CORZ), ha depositato materiali elettorali definitivi aggiuntivi chiedendo una votazione CONTRO la proposta vendita a CoreWeave (annunciata il 7 luglio 2025). In una lettera agli azionisti, Two Seas sostiene che l’accordo sia valutato in modo sostanzialmente inferiore a Core Scientific.
La società cita un valore implicito di circa $17,50 per azione basato sul rapporto di cambio 0,1235 e sul prezzo delle azioni di CoreWeave del 16 ottobre 2025, osservando che CORZ è stato scambiato al di sopra del valore implicito giornaliero della trattativa per 44 giorni di negoziazione consecutivi, in media del 13%. Two Seas evidenzia transazioni del settore e la performance delle azioni dei peers per suggerire un potenziale al rialzo maggiore da solo e invita gli azionisti a utilizzare la scheda proxy GOLD per votare contro la transazione.
Two Seas Capital, un importante accionista de Core Scientific (NASDAQ: CORZ), presentó materiales definitivos de poder adicionales instando a votar EN CONTRA la propuesta venta a CoreWeave (anunciada el 7 de julio de 2025). En una carta a los accionistas, Two Seas argumenta que el acuerdo subestima sustancialmente a Core Scientific.
La firma cita un valor implícito de aproximadamente $17.50 por acción basado en la proporción de intercambio 0.1235 y el precio de las acciones de CoreWeave el 16 de octubre de 2025, señalando que [CORZ] ha cotizado por encima del valor diario implícito del acuerdo durante 44 días hábiles consecutivos, con un promedio del 13%. Two Seas destaca transacciones del sector y el desempeño de las acciones pares para sugerir mayor potencial alcista independiente y solicita a los accionistas usar la tarjeta proxy GOLD para votar en contra de la transacción.
Two Seas Capital은 Core Scientific(NASDAQ: CORZ)의 주요 주주로, 제안된 매각을 반대하기 위해 CoreWeave에 대한 매매를 촉구하는 결정적 추가 위임 자료를 제출했습니다(2025년 7월 7일 발표). 주주들에게 보내는 서한에서 Two Seas는 거래가 Core Scientific를 실질적으로 저평가하고 있다고 주장합니다.
이 회사는 주당 약 $17.50의 암시적 가치를 0.1235의 교환 비율과 CoreWeave의 2025년 10월 16일 주가를 기준으로 제시하며, CORZ가 연속 44거래일 동안 거래가치가 일일 암시 가치보다 높게 형성되었고 평균 13% 차이였다고 지적합니다. Two Seas는 업계 거래와 동종 또래의 주가 성과를 강조하여 독립적인 상승 여지가 더 크다고 시사하고, 주주들에게 거래에 반대하기 위해 GOLD 대리 카드를 사용해 달라고 요청합니다.
Two Seas Capital, un important actionnaire de Core Scientific (NASDAQ: CORZ), a déposé des documents spécifiques d’instructions additionnels appelant à voter CONTRE la vente proposée à CoreWeave (annoncée le 7 juillet 2025). Dans une lettre aux actionnaires, Two Seas soutient que l’accord évalué de manière substantielle inférieure à Core Scientific.
La société cite une valeur implicite d’environ $17,50 par action basée sur le ratio d’échange 0,1235 et le cours de CoreWeave du 16 octobre 2025, notant que le titre CORZ s’est négocié au-dessus de la valeur implicite quotidienne de l’opération pendant 44 jours de bourse consécutifs, en moyenne de 13%. Two Seas met en avant les transactions sectorielles et la performance des actions des pairs pour suggérer un potentiel de hausse autonome plus important et invite les détenteurs à utiliser la carte de procuration GOLD pour voter contre la transaction.
Two Seas Capital, ein bedeutender Aktionär von Core Scientific (NASDAQ: CORZ), reichte endgültige zusätzliche Proxy-Unterlagen ein, die zu einer Gegenstimme der vorgeschlagenen Veräußerung an CoreWeave aufrufen (am 7. Juli 2025 bekannt gegeben). In einem Brief an die Aktionäre argumentiert Two Seas, dass das Geschäft erheblich unterbewertet ist.
Das Unternehmen verweist auf einen implizierten Wert von etwa $17,50 pro Aktie basierend auf dem Umtauschverhältnis 0,1235 und CoreWeaves Aktienkurs vom 16. Oktober 2025 und stellt fest, dass CORZ über 44 aufeinanderfolgende Handelstage über dem täglichen impliziten Transaktionswert gehandelt hat, im Durchschnitt um 13%. Two Seas hebt Sektorstransaktionen und die Performance von Peer-Aktien hervor, um eine größere eigenständige Aufwärtsseite zu suggerieren, und bittet die Inhaber, die GOLD-Proxy-Karte zu verwenden, um gegen die Transaktion zu stimmen.
Two Seas Capital، أحد كبار المساهمين في Core Scientific (ناسداك: CORZ)، قد قدّم مواد تفويض إضافية حاسمة تحث على التصويت ضد البيع المقترح إلى CoreWeave (أُعلن في 7 يوليو 2025). في رسالة إلى المساهمين، يجادل Two Seas بأن الصفقة تقلل من قيمة Core Scientific بشكل جوهري.
تشير الشركة إلى قيمة ضمنية قدرها حوالي $17.50 للسهم استنادًا إلى نسبة التبادل 0.1235 وأسهم CoreWeave في 16 أكتوبر 2025، مع الإشارة إلى أن CORZ قد تم تداوله فوق القيمة اليومية الضمنية للصفقة لمدة 44 يومًا تداوليًا متتاليًا، وبمتوسط زيادة قدره 13%. يسلط Two Seas الضوء على المعاملات القطاعية وأداء أسهم نظرائها لاقتراح وجود جانبية صاعدة أقوى بشكل مستقل ويطلب من حاملي الأسهم استخدام بطاقة التوكيل GOLD للتصويت ضد الصفقة.
Two Seas Capital，Core Scientific（纳斯达克股票代码：CORZ）的主要股东，提交了决定性的额外代理材料，敦促对拟向 CoreWeave 的出售投票<对>（于 2025 年 7 月 7 日宣布）。在致股东的信中，Two Seas 认为该交易对 Core Scientific 的估值严重低估。
该公司引用一个大约 $17.50 每股的隐含价值，基于 0.1235 的换股比率以及 CoreWeave 2025 年 10 月 16 日的股价，指出 CORZ 已经在 44 个交易日的日内隐含交易价值之上交易，平均高出 13%。Two Seas 强调行业交易和同业股的表现，以暗示更大的独立上涨空间，并请持股者使用 GOLD 代理卡对交易投反对票。
- None.
- None.
Insights
Shareholder solicits votes against merger; valuation dispute.
Two Seas Capital is running a definitive solicitation to block Core Scientific’s sale to CoreWeave. The core claim is pricing: an implied consideration near
This is a classic valuation contest in a hot HPC/AI infrastructure market. The filing presents peer moves and recent large deals as comparables, but those are advocacy points from the proponent. Actual impact depends on shareholder voting outcomes and any revised terms.
Key decision points are the special meeting vote and any company responses or updates to consideration. If the deal is rejected, subsequent disclosures may outline alternatives.
Two Seas Capital, un importante socio di Core Scientific (NASDAQ: CORZ), ha depositato materiali elettorali definitivi aggiuntivi chiedendo una votazione CONTRO la proposta vendita a CoreWeave (annunciata il 7 luglio 2025). In una lettera agli azionisti, Two Seas sostiene che l’accordo sia valutato in modo sostanzialmente inferiore a Core Scientific.
La società cita un valore implicito di circa $17,50 per azione basato sul rapporto di cambio 0,1235 e sul prezzo delle azioni di CoreWeave del 16 ottobre 2025, osservando che CORZ è stato scambiato al di sopra del valore implicito giornaliero della trattativa per 44 giorni di negoziazione consecutivi, in media del 13%. Two Seas evidenzia transazioni del settore e la performance delle azioni dei peers per suggerire un potenziale al rialzo maggiore da solo e invita gli azionisti a utilizzare la scheda proxy GOLD per votare contro la transazione.
Two Seas Capital, un importante accionista de Core Scientific (NASDAQ: CORZ), presentó materiales definitivos de poder adicionales instando a votar EN CONTRA la propuesta venta a CoreWeave (anunciada el 7 de julio de 2025). En una carta a los accionistas, Two Seas argumenta que el acuerdo subestima sustancialmente a Core Scientific.
La firma cita un valor implícito de aproximadamente $17.50 por acción basado en la proporción de intercambio 0.1235 y el precio de las acciones de CoreWeave el 16 de octubre de 2025, señalando que [CORZ] ha cotizado por encima del valor diario implícito del acuerdo durante 44 días hábiles consecutivos, con un promedio del 13%. Two Seas destaca transacciones del sector y el desempeño de las acciones pares para sugerir mayor potencial alcista independiente y solicita a los accionistas usar la tarjeta proxy GOLD para votar en contra de la transacción.
Two Seas Capital은 Core Scientific(NASDAQ: CORZ)의 주요 주주로, 제안된 매각을 반대하기 위해 CoreWeave에 대한 매매를 촉구하는 결정적 추가 위임 자료를 제출했습니다(2025년 7월 7일 발표). 주주들에게 보내는 서한에서 Two Seas는 거래가 Core Scientific를 실질적으로 저평가하고 있다고 주장합니다.
이 회사는 주당 약 $17.50의 암시적 가치를 0.1235의 교환 비율과 CoreWeave의 2025년 10월 16일 주가를 기준으로 제시하며, CORZ가 연속 44거래일 동안 거래가치가 일일 암시 가치보다 높게 형성되었고 평균 13% 차이였다고 지적합니다. Two Seas는 업계 거래와 동종 또래의 주가 성과를 강조하여 독립적인 상승 여지가 더 크다고 시사하고, 주주들에게 거래에 반대하기 위해 GOLD 대리 카드를 사용해 달라고 요청합니다.
Two Seas Capital, un important actionnaire de Core Scientific (NASDAQ: CORZ), a déposé des documents spécifiques d’instructions additionnels appelant à voter CONTRE la vente proposée à CoreWeave (annoncée le 7 juillet 2025). Dans une lettre aux actionnaires, Two Seas soutient que l’accord évalué de manière substantielle inférieure à Core Scientific.
La société cite une valeur implicite d’environ $17,50 par action basée sur le ratio d’échange 0,1235 et le cours de CoreWeave du 16 octobre 2025, notant que le titre CORZ s’est négocié au-dessus de la valeur implicite quotidienne de l’opération pendant 44 jours de bourse consécutifs, en moyenne de 13%. Two Seas met en avant les transactions sectorielles et la performance des actions des pairs pour suggérer un potentiel de hausse autonome plus important et invite les détenteurs à utiliser la carte de procuration GOLD pour voter contre la transaction.
Two Seas Capital, ein bedeutender Aktionär von Core Scientific (NASDAQ: CORZ), reichte endgültige zusätzliche Proxy-Unterlagen ein, die zu einer Gegenstimme der vorgeschlagenen Veräußerung an CoreWeave aufrufen (am 7. Juli 2025 bekannt gegeben). In einem Brief an die Aktionäre argumentiert Two Seas, dass das Geschäft erheblich unterbewertet ist.
Das Unternehmen verweist auf einen implizierten Wert von etwa $17,50 pro Aktie basierend auf dem Umtauschverhältnis 0,1235 und CoreWeaves Aktienkurs vom 16. Oktober 2025 und stellt fest, dass CORZ über 44 aufeinanderfolgende Handelstage über dem täglichen impliziten Transaktionswert gehandelt hat, im Durchschnitt um 13%. Two Seas hebt Sektorstransaktionen und die Performance von Peer-Aktien hervor, um eine größere eigenständige Aufwärtsseite zu suggerieren, und bittet die Inhaber, die GOLD-Proxy-Karte zu verwenden, um gegen die Transaktion zu stimmen.
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a)
of the Securities Exchange Act of 1934
Filed by the Registrant ¨
Filed by a Party other than the Registrant þ
Check the appropriate box:
| ¨ | Preliminary Proxy Statement |
| ¨ | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
| ¨ | Definitive Proxy Statement |
| þ | Definitive Additional Materials |
| ¨ | Soliciting Material Under Rule 14a-12 |
Core Scientific, Inc.
(Name of Registrant as Specified In Its Charter)
Two Seas Capital LP
Two Seas Capital GP LLC
Sina Toussi
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
| þ | No fee required. |
| ¨ | Fee paid previously with preliminary materials. |
| ¨ | Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. |
On October 17, 2025, Two Seas Capital LP issued the following press release.
Two Seas Capital Highlights Significant Value Upside for Core Scientific Shareholders If They Reject the Proposed Sale to CoreWeave
Issues Letter to Shareholders Citing Market Evidence Demonstrating the Proposed Transaction Substantially Undervalues Core Scientific
Urges Shareholders to Vote AGAINST the Proposed Transaction on the GOLD Proxy Card
NEW YORK, October 17, 2025 -- Two Seas Capital LP (“Two Seas” or “we”), an alternative investment management firm and one of the largest shareholders of Core Scientific, Inc. (“Core Scientific” or the “Company”) (NASDAQ: CORZ), today issued a letter to shareholders in connection with its opposition to the Company’s proposed sale to CoreWeave, Inc. (“CoreWeave”) (NASDAQ: CRWV) on the terms announced on July 7, 2025.
The full text of the letter is below.
* * *
October 17, 2025
Dear Fellow Core Scientific Shareholders:
The accelerating AI build-out is driving insatiable demand for power and high-performance computing (“HPC”) assets and shows no signs of slowing.
Since Core Scientific and CoreWeave announced their intention to combine more than three months ago, there has been a wave of multi-billion-dollar deals1 involving hyperscalers, AI Labs, power companies, neoclouds, and data center companies (including former Bitcoin miners) like Core Scientific. The most recent came earlier this week, when a consortium of companies leading the AI revolution acquired a portfolio of data centers for $40 billion – among the largest data center deals ever.
The unprecedented investment in the AI infrastructure build-out has led to a surge in the equity values of HPC data center companies. The stock prices of each of Core Scientific’s three closest peers, Applied Digital, Cipher Mining and TeraWulf – each a former Bitcoin miner with HPC contracts – have approximately tripled since the announcement of the Company’s proposed sale to CoreWeave, and nearly quadrupled since rumors of the proposed sale first emerged in June 2025.2
__________________________________
1 See, for example, the $40 billion acquisition of Aligned Data Centers by a consortium including Nvidia, Microsoft, BlackRock and xAI (October 15, 2025); Oracle’s $300 billion deal with OpenAI for computing infrastructure (September 10, 2025); Cipher Mining’s AI hosting contract with Fluidstack for up to $10 billion, backstopped by Google (September 25, 2025); Microsoft’s $17 billion deal with Nebius for HPC infrastructure; and TeraWulf’s AI hosting contract with Fluidstack for up to $16 billion, backstopped by Google (August 18, 2025).
2 Stock price returns measured from June 25, 2025 (the last trading day prior to media reports regarding a potential merger) and July 3, 2025 (the last trading day prior to the announcement of the merger) to October 16, 2025.
Unfortunately, as Core Scientific shareholders, we have not benefited from this rising tide that has lifted all other boats. Core Scientific’s stock has been left well behind, tethered to CoreWeave’s stock, which has declined by approximately 15% since the proposed transaction was announced.3 As a result, Core Scientific’s stock is up a mere 9% since the acquisition was announced.
Stock Price Returns Since Merger Announcement
In the absence of the proposed transaction, had Core Scientific stock merely performed in-line with the Company’s worst-performing peer, it would be trading around $45 per share.4 Instead, Core Scientific shareholders are being asked to convert their shares into CoreWeave’s volatile and underperforming stock at an implied value of just ~$17.50 per share.5
We see no reason why Core Scientific shareholders should accept such an underwhelming deal. Based on recent trading data, we see little evidence that they will.
As of yesterday’s close, Core Scientific’s stock was trading 12% higher than the current deal value. Indeed, Core Scientific’s stock has traded higher than the implied deal value for 44 straight trading days, on some days by more than 20%.6 The widening divide between Core Scientific’s trading price and the value of the merger consideration has resulted in a negative
_________________
3 Id.
4 Illustrative Core Scientific stock price reflects the lowest stock price return of Applied Digital, Cipher Mining and TeraWulf from June 25, 2025 (the last trading day prior to media reports regarding a potential merger) and July 3, 2025 (the last trading day prior to the announcement of the merger) to October 16, 2025, which was 265% and 163%, respectively, as applied to Core Scientific’s stock price on those dates, resulting in illustrative stock prices of $44.86 and $47.43, respectively.
5 Implied value equal to CoreWeave’s stock price on October 16, 2025, multiplied by the merger exchange ratio of 0.1235 shares of CoreWeave for each share of Core Scientific.
6 Core Scientific’s stock price has closed higher than the daily implied value of the merger consideration (based on CoreWeave’s closing stock price and the merger exchange ratio) since August 14, 2025, by an average of 13% and 20% or more on 10 days.
deal spread that has persisted since the post-IPO lock-up period on CoreWeave’s stock expired on August 14.
The market is clearly skeptical of this merger, and for good reason: CoreWeave is attempting to acquire Core Scientific at a valuation that does not reflect the Company’s opportunity, at a time of unprecedented value creation across the sector.
We firmly believe Core Scientific’s alternatives are far superior to this flawed transaction. We urge our fellow shareholders to join us in voting AGAINST the proposed transaction on the GOLD proxy card, so that Core Scientific shareholders can realize further upside from owning one of the best assets in the AI landscape.
Sincerely,
Sina Toussi
Founder, President and Chief Investment Officer
Two Seas Capital LP
About Two Seas Capital LP
Two Seas, founded in 2020 and led by Chief Investment Officer Sina Toussi, specializes in event-driven investing anchored by rigorous fundamental research and a targeted focus on special situations. With approximately $1.9 billion in assets under management, Two Seas' approach is designed to uncover market inefficiencies where value can be realized through the resolution of legal and regulatory events. The Two Seas team is highly regarded for its rigorous due diligence and its ability to translate complex and dynamic scenarios into actionable investment opportunities.
Contacts
Investors
Scott Winter / Jonathan Salzberger
Innisfree M&A Incorporated info@innisfreema.com
(212) 750-5833
Media
Steve Bruce / Taylor Ingraham / Keely Gispan
ASC Advisors
twoseas@ascadvisors.com
(203) 992-1230
Disclaimer
This press release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities described herein in any state to any person. This press release does not recommend the purchase or sale of a security. There is no assurance or guarantee with respect to the prices at which any securities of Core Scientific or CoreWeave will trade, and such securities may not trade at prices that may be implied herein. In addition, this press release and the discussions and opinions herein are for general information only, and are not intended to provide investment advice.
This press release contains forward-looking statements. Forward-looking statements are statements that are not historical facts and may include projections and estimates and their underlying assumptions, statements regarding plans, objectives, intentions and expectations with respect to future financial results, events, operations, services, product development and potential, and statements regarding future performance. Forward-looking statements are generally identified by the words "expects", "anticipates", "believes", "intends", "estimates", "plans", "will be" and similar expressions. Although Two Seas believes that the expectations reflected in forward-looking statements contained herein are reasonable, investors are cautioned that forward-looking information and statements are subject to various risks and uncertainties—many of which are difficult to predict and are generally beyond the control of Two Seas, Core Scientific or CoreWeave—that could cause actual results and developments to differ materially from those expressed in, or implied or projected by, the forward-looking information and statements. In addition, the foregoing considerations and any other publicly stated risks and uncertainties should be read in conjunction with the risks and cautionary statements discussed or identified in Core Scientific and CoreWeave's respective public filings with the U.S. Securities and Exchange Commission, including those listed under "Risk Factors" in annual reports on Form 10-K and quarterly reports on Form 10-Q and those related to the pending transaction involving Core Scientific and CoreWeave (the "Pending Transaction"). The forward-looking statements speak only as of the date hereof and, other than as required by applicable law, Two Seas does not undertake any obligation to update or revise any forward-looking information or statements. Certain information included in this material is based on data obtained from sources considered to be reliable. Any analyses provided to assist the recipient of this material in evaluating the matters described herein may be based on subjective assessments and assumptions and may use one among alternative methodologies that produce different results. Accordingly, any analyses should not be viewed as factual and should not be relied upon as an accurate prediction of future results.
All figures are unaudited estimates and, unless required by law, are subject to revision without notice.
Funds and investment vehicles (collectively, the "Two Seas Funds") managed by Two Seas currently beneficially own shares of Core Scientific and CoreWeave. The Two Seas Funds are in the business of trading (i.e., buying and selling) securities and intend to continue trading in the securities of Core Scientific and CoreWeave. You should assume the Two Seas Funds will from time to time sell all or a portion of their holdings of Core Scientific and/or CoreWeave in open market transactions or otherwise, buy additional shares (in open market or privately negotiated transactions or otherwise), or trade in options, puts, calls, swaps or other derivative instruments relating to such shares. Consequently, Two Seas' beneficial ownership of shares of, and/or economic interest in, Core Scientific and/or CoreWeave may vary over time depending on various factors, with or without regard to Two Seas' views of the Pending Transaction or Core Scientific and/or CoreWeave's respective businesses, prospects, or valuations (including the market price of Core Scientific and/or CoreWeave shares), including, without limitation, other investment opportunities available to Two Seas, concentration of positions in the portfolios managed by Two Seas, conditions in the securities markets, and general economic and industry conditions. Without limiting the generality of the foregoing, in the event of a change in Core Scientific and/or CoreWeave's respective share prices on or following the date hereof, the Two Seas Funds may buy additional shares or sell all or a portion of their holdings of Core Scientific and/or CoreWeave (including, in each case, by trading in options, puts, calls, swaps, or other derivative instruments). Two Seas also reserves the right to change the opinions expressed herein and its intentions with respect to its investments in Core Scientific and CoreWeave, and to take any actions with respect to its investments in Core Scientific and CoreWeave as it may deem appropriate, and disclaims any obligation to notify the market or any other party of any such changes or actions, except as required by law.
Important Information
Two Seas, Two Seas Capital GP LLC ("Two Seas GP"), and Sina Toussi ("Mr. Toussi" and, together with Two Seas and Two Seas GP, the "Participants") have filed a definitive proxy statement and GOLD proxy card (the "Proxy Statement") with the SEC on September 29, 2025 to be used to solicit proxies for votes against the proposed acquisition of Core Scientific by CoreWeave at the upcoming special meeting of the Company's shareholders. THE PARTICIPANTS STRONGLY ADVISE ALL SHAREHOLDERS OF THE COMPANY TO READ THE PROXY STATEMENT AND OTHER PROXY MATERIALS BECAUSE THEY CONTAIN IMPORTANT INFORMATION. SUCH PROXY MATERIALS ARE AVAILABLE AT NO CHARGE ON THE SEC'S WEBSITE AT HTTP://WWW.SEC.GOV. IN ADDITION, THE PARTICIPANTS WILL PROVIDE COPIES OF THE PROXY STATEMENT WITHOUT CHARGE UPON REQUEST.
Additional information about the Participants and a description of their direct or indirect interests by security holdings or otherwise can be found in Exhibit 2 of the Schedule 14A filed by Two Seas with the SEC on October 10, 2025.
SOURCE Two Seas Capital
